Keywords: intermune, roche, hcv, licensing, deal, usa-based, biotechnology

InterMune and Roche in HCV licensing deal

Article | 13 November 2006

USA-based biotechnology company firm InterMune says that it has signed an exclusive collaboration agreement with Swiss drug major Roche, under ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Roche

Go to company listing